SKN Price sensitive 30 Apr 2026, 5:59 PM

Quarterly Activities/Appendix 4C Cash Flow Report

Skin Elements Ltd

Skin Elements Delivers Strong Quarterly Results

Key points

  • SE Formula Biotechnology Commercialisation Ready Across Five Formulations
  • ECO Nurture Kiwifruit Evaluation Complete, Awaiting New Zealand Approval
  • SuprCuvr High Performance ECO Nurture Kiwifruit Evaluation Complete

Full summary

Skin Elements Limited (ASX: SKN), a world leader in the development of Australian all natural antimicrobial biotechnology, has provided its Quarterly Activity Report for the quarter ending 31 March 2026. The company's SE Formula antimicrobial biotechnology platform continues to meet milestone completions in readiness for initial product commercialisation of its first core GREEN - Tech product ranges. The company has also completed extensive evaluation of its ECO-Nurture sustainable, horticultural plant infection control technology in kiwifruit orchards in New Zealand and is now awaiting government approval. Additionally, the company's SuprCuvr high performance disinfectant cleaner, made from the company's proprietary 100% plant-based formula, has been adopted by Spotless for cleaning and disinfecting of train carriages and stations in Melbourne. The company's Soleo Organics sunscreen formulations have been independently verified and certified, and the company's PapayaActivs therapeutics skincare and Elizabeth Jane Natural Cosmetics ranges are also progressing towards commercialisation. The company continues to be eligible for the Federal Government's R&D Rebate and has prudently managed its operational cashflows.

Outlook

The company's sales programmes are well positioned to drive growth in 2026, with strong field evaluation outcomes from its SE Formula SuprCuvr natural disinfectant and ECO Nurture agriculture bio-stimulant programmes, as well as independent verification of its Soleo Organics sunscreen formulations.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in